Find support for living with CIDP

A wide range of financial, community, and nurse support is available from CSL Behring.

Get support

How is CIDP treated?

The only FDA-approved treatment for CIDP is immunoglobulins (Ig)—antibodies that occur naturally in the immune system. Obtained from healthy volunteers and infused into your body, Ig therapy has been shown to improve motor function in adults with CIDP.

What can I expect with Privigen IVIg?

Privigen was proven safe and effective in 2 clinical studies for CIDP. PRIMA studied 28 people and PATH studied 207.

  • Overall, 61% of patients responded to Privigen therapy in PRIMA, and 73% responded in PATH
  • In PRIMA and PATH, 94% and 99% of people whose motor function improved with Privigen saw improvement by the third maintenance treatment

What about side effects?

The clinical studies also showed that Privigen IVIg infusion is safe and effective in the treatment of CIDP

  • 97% of the side effects patients had with Privigen were mild or moderate in intensity for both trials
    • 2 patients in the PRIMA study and 8 patients in PATH had serious side effects
  • In clinical trials of Privigen for CIDP, headache was the most common side effect. Other common side effects for CIDP treatment include fatigue, nausea, fever, and high blood pressure
  • Serious adverse reactions seen in both trials included hemolysis (2), exacerbation of CIDP (2), acute rash, increased blood pressure, hypersensitivity, pulmonary embolism, respiratory failure, and migraine
  • These are not the only side effects possible; see the full prescribing information, including boxed warning, for a complete list of adverse reactions possible with treatment for each condition. Alert your physician to any side effect that bothers you or does not go away.
You are now leaving the current website.

Do you want to continue?

Welcome to Privigen.com.

Help us find the right content for you.